ABSTRACT
B
lood oxygenation level-dependent (BOLD) fMRI is becoming increasing used for presurgical mapping of eloquent cortex before resection of brain tumors 1 or epileptogenic foci 2 and to assess cerebrovascular reactivity (CVR) when combined with hypercapnic gas stimuli. 3, 4 The main advantage of BOLD fMRI is the lack of ionizing radiation or exogenous contrast required, which makes it a particularly appealing approach for longitudinal monitoring of patients or for evaluating short-term responses to therapy in situations in which exogenous contrast agents may be dose-restricted.
A known limitation of BOLD fMRI over alternative approaches for assessing hemodynamics is the sensitivity of BOLD to magnetic field inhomogeneities, including those produced by implants. At clinical field strengths of 1.5T to 3T, BOLD fMRI requires a relatively long TE (30 -55 ms) to sensitize the sequence to susceptibility differences between oxygenated (diamagnetic) and deoxygenated (paramagnetic) blood. However, this require-ment also sensitizes the sequence to susceptibility variations between implants and surrounding tissue. This feature adds variability to the static magnetic field (B0) and may manifest as distortion or signal voids.
The influence of implants on the quality of the diagnostic information has been historically defined as "MR imaging compatibility." Medical devices labeled "MR imaging compatible" were MR imaging-safe and did not affect the quality of the diagnostic information. However, due to ongoing confusion with medical labeling, in 2005, the US Food and Drug Administration recognized a new set of terms by the American Society for Testing and Materials international, which included the influence of implants on image quality, and requested manufacturers to use the terminology for new products. However, there remains a fundamental need to define the extent of image artifacts, because manufacturers frequently provide only general statements regarding the possible impact on image quality. 5 Furthermore, such MR imaging compatibility is most commonly considered in the context of conventional structural MR imaging sequences that use short TEs, [6] [7] [8] avoid single-shot echo-planar imaging readouts, and/or may not use parallel imaging, all of which are commonly used in BOLD fMRI. Thus, the impact of implants specifically on BOLD fMRI signal quality is not well-characterized. For cerebral hemodynamic measurements derived from BOLD MR imaging to be reliable in routine clinical practice, susceptibility-induced influences of endovascular and surgical hardware on BOLD MR imaging must be characterized, particularly in studies that require imaging before and after implantation of surgical hardware. The purpose of this study was to review BOLD fMRI examinations performed clinically at 3T and to calculate the volume and artifact extent in patients with implants, as well as the degree to which the artifact impacts the clinical utility of the study. This information is intended to serve as an exemplar for when BOLD fMRI scans may remain interpretable, even in the presence of surgically implanted hardware.
MATERIALS AND METHODS

Patient Demographics and Ethical Considerations
This study was approved by our local institutional review board and conformed to the requirements of the United States Health Insurance Portability and Accountability Act. We conducted a retrospective analysis of all BOLD MRI acquired clinically (January 2006 to March 2014) at our institution as part of 2 separate institutional review board-approved studies. In one study, patients were prospectively recruited to undergo BOLD MR imaging by using a CVR protocol (institutional review board No. 110468, n ϭ 80). Additionally, clinical BOLD MR imaging was performed by using a protocol with functional tasks for language or motor localization (functional localizer protocol, n ϭ 263). An institutional review board exemption was obtained to retrospectively review data from the functional localizer protocol (institutional review board No. 150190). Implant manufacturer and model were obtained when available in the electronic medical record, and all patients were screened per departmental policy to determine the MR imaging compatibility and safety of implants before scanning, following the American College of Radiology recommendations for safe MR imaging practices.
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MR Imaging Parameters
All patients in the CVR protocol were scanned by using 3T MR imaging (Achieva; Phillips Healthcare, Best, the Netherlands) with body coil transmission and sensitivity encoding 8-array coil reception with a multimodal protocol, which included hypercarbic BOLD: spatial resolution ϭ 3.4 ϫ 3.4 ϫ 5 mm 3 , single-shot gradient-echo EPI, TR/TE ϭ 2000/35 ms, flip angle ϭ 80°, sensitivity encoding factor ϭ 2, 30 sections; and a block paradigm of 3/3 minutes baseline (room air)/5% carbogen (5% CO 2 , 95% O 2 ) breathing repeated twice. Patients undergoing the functional localizer protocol were scanned by using the same scanner with a slightly modified protocol: spatial resolution ϭ 3.75 ϫ 3.75 ϫ 5.00 mm 3 , single-shot gradient-echo EPI, TR/TE ϭ 2000/35 ms, flip angle ϭ 78°, sensitivity encoding factor ϭ 1.8, 30 sections. The TE and readout type (single-shot gradient-echo EPI) were identical for both protocols; the total voxel volume (57.8 versus 52.7 mm 3 ) and parallel imaging factor (2.0 versus 1.8) were nearly identical between protocols and within the range of common fMRI acquisition parameters (see "Discussion").
Analysis
All fMRI data were corrected for motion and baseline drift and were coregistered to T1 and standard space (Montreal Neurological Institute, 2 mm) by using linear registration routines from the fMRI of the Brain Software Library (FSL; http://www.fmrib.ox. ac.uk/fsl). 10 Dephasing artifacts associated with metallic objects on BOLD MR imaging were overseen by a board-certified neuroradiologist (M.K.S. with 13 years' experience) and were quantified on all patients with implanted hardware by manually drawing ROIs demarcating areas of signal loss on each affected image section (Fig 1) . These data were then summed to yield a total artifact volume (cubic centimeters). In patients with multiple ipsilateral implants, artifact volume per hemisphere was summated, because implant proximity precluded the ability to distinguish the extent of artifacts associated with each individual implant in subjects with bilateral implants. In patients with bilateral implants, right and left hemisphere artifacts were calculated separately. Additional analysis was performed to calculate the time course signal-to-noise ratio in each voxel by measuring the ratio of the mean baseline signal to the SD of the baseline signal with time.
All BOLD MRIs were reviewed by a fellowship-trained, boardcertified neuroradiologist (M.K.S) and a MR imaging physicist (V.L.M. with 15 years' experience) to characterize the degree that artifact volume impacted clinical interpretability by using the following scale: none ϭ no compromise of functional interpretation from hardware artifact (eg, hardware artifacts do not project onto the parenchyma); mild ϭ hardware artifacts present but do not compromise clinical interpretation; moderate ϭ hardware artifacts somewhat limit, but do not preclude, clinical interpretation; severe ϭ hardware artifacts preclude clinical interpretation.
RESULTS
In patients in the CVR protocol, 26 of 80 (32.5%) had surgical hardware: intracranial implants (n ϭ 5), extracranial hardware (n ϭ 19), and ventriculoperitoneal (VP) shunts (n ϭ 2). Intracranial implant characteristics are summarized in Table 1 . Implanted extracranial hardware (On-line Table 1 ) primarily included closure hardware composed of titanium alloy and 1 patient with a polyethylene implant. Six of 19 patients had bilateral closure hardware with artifact sizes calculated separately by hemisphere, for a total of 25 hemispheres. Implanted VP shunts are described in On-line Table 2 . Artifacts from surgically implanted hardware are shown in Table 2 .
In patients in the functional localizer protocol, 14 of 263 (5.3%) had surgical hardware: extracranial hardware (n ϭ 13) and VP shunt (n ϭ 1). Extracranial hardware comprised surgical closure hardware, and implant records were not available for these patients. The implanted VP shunt is included in On-line Table 2 .
Mean artifact volume associated with intracranial hardware in patients undergoing the CVR protocol was 4.3 Ϯ 3.2 cm 3 ; range ϭ 1.1-9.4 cm 3 . As a point of reference, the average volume of the adult human brain is approximately 1380 cm 3 . 11 The small artifact volume associated with implanted intracranial hardware did not compromise the functional interpretation of cerebral hemodynamic data, with intracranial implants considered to have no (n ϭ 3) or mild (n ϭ 3) effect on the clinical interpretability of the examination in the affected hemisphere. Figure 2 shows a representative image maximally affected by implanted intracranial hardware and hemodynamic data from a patient with a left MCA stent with in-stent restenosis, demonstrating the impact of the artifacts on the reactivity map. Mean artifact volume of extracranial hardware in patients in the CVR protocol was 28.4 Ϯ 14.0 cm 3 ; range ϭ 6.1-61.7 cm 3 ;
and in patients in the functional localizer protocol, it was 39.9 Ϯ 27.0 cm 3 (range ϭ 6.9 -77.1 cm 3 ). Artifact volume associated with titanium closure hardware is typically small and peripheral, with 19 of the evaluated hemispheres (76%) considered to have mild artifacts, which did not compromise clinical interpretation of cerebral hemodynamics (Fig 3) . Closure hardware artifacts in 5 of the evaluated hemispheres (20%) had a moderate effect on the clinical interpretation. However, in the patient (patient 10) with the largest number of maxDrive screws (KLS-Martin, Jacksonville, Florida), 12 artifact size (61.7 cm 3 ) was rated as severe and precluded ipsilateral CVR interpretation in the region of the indirect revascularization that underlay the closure hardware (Fig 4) . These artifacts were larger than those in other patients with fewer KLS-Martin LP maxDrive screws (patient 20: 5 screws, artifact volume ϭ 17.1 cm 3 ; , and were rated as severe in 2 of 3 patients (Fig 5, CVR protocol) and moderate in the remaining patient (functional localizer protocol).
DISCUSSION
Specificity of Different Implants on BOLD fMRI Artifact Volume
Dephasing artifacts on MR imaging associated with implanted devices are caused by perturbations in the magnetic field due to differences in magnetic susceptibility or the degree of magnetization of an object in the presence of a magnetic field between the implanted device and surrounding tissue. Larger differences in 3 ) associated with surgical closure hardware, attributable to the large number of KLS-Martin maxDrive screws. Artifacts were thought to severely impact clinical interpretation of the study, and hemodynamic evaluation with temporal signal-to-noise ratio maps (B) and reactivity maps (C) shows that interpretable hemodynamic data were not obtainable near the closure hardware. tSNR indicates temporal signal-to-noise ratio. magnetic susceptibility between an implanted device and surrounding tissue lead to larger perturbations of the magnetic field and greater spectral dispersion of spins within a voxel, resulting in more extensive dephasing artifacts. In BOLD fMRI, long-TE, T2*-weighted imaging is used to sensitize the sequence to susceptibility differences between oxygenated and deoxygenated blood, but these imaging parameters also render the sequence exquisitely sensitive to susceptibility variations from magnetic field inhomogeneities, exacerbating artifact extent. [6] [7] [8] The effect of increased dephasing artifacts associated with implants on the quality of data obtained specifically from BOLD MR imaging has not been previously well-documented, to our knowledge. Our results demonstrate that BOLD MR imaging is interpretable in the presence of most implants evaluated, except for VP shunts, particularly those with programmable valves and siphon gauges and 1 patient with multiple KLS-Martin maxDrive screws. The intracranial implants and extracranial hardware analyzed are composed of materials with low magnetic susceptibilities, such as titanium, nickel, platinum, or their alloys. All intracranial implanted devices produced small artifacts that had no-to-mild effects on clinical interpretability, and closure hardware typically resulted in small, peripheral artifacts that did not preclude interpretation. The single notable exception was a patient with a large number of KLS-Martin maxDrive screws, which were associated with more artifacts than the KLS-Martin Cross-Drive screws. While both the maxDrive and Cross-Drive screws are made of a titanium and nickel alloy, the maxDrive screw has a larger head profile. The number of screws did not correlate directly with artifacts across screw types.
In contrast, VP shunts resulted in large artifacts that produced a moderate-to-severe impact on clinical interpretation, an effect attributable to the shunt valve composition. The valve portion of the VP shunt is composed of 316L stainless steel in addition to unalloyed titanium and tantalum in some models. 12, 13 Stainless steel contains iron, a ferromagnetic substance. While 316L stainless steel contains a larger amount of nickel, which stabilizes iron in its nonmagnetic state and reduces its magnetic susceptibility, its magnetic susceptibility remains larger relative to titanium, resulting in larger perturbations of the magnetic field and more extensive artifacts. 14, 15 In addition, the Certas programmable valve (Codman & Shurtleff, Raynham, Massachusetts) contains neodymium magnets, which caused extensive signal loss 13, 16, 17 and likely contributed to the large artifact volume (139.6 cm 3 )
relative to other VP shunts evaluated (64.0 and 83.5 cm 3 ).
Studies have described the effect of previously implanted surgical hardware on BOLD fMRI in the preoperative evaluation of brain tumor resection, demonstrating that language lateralization and primary motor cortex activation can be ascertained despite a reduction in total volume activation due to susceptibility artifacts. 18, 19 Our study confirms the feasibility of obtaining data despite implants, which is particularly important in patients with cerebrovascular disease because longitudinal monitoring of patients before and after revascularization may be desired.
Imaging Parameters and Artifact Volume
Artifact volume will vary with imaging readout and scan parameters. 20 We have used scan parameters that are common for BOLD fMRI on all major vendor platforms, including single-shot gradient-echo EPI, voxel volume ϭ 50 -60 mm 3 , and TE centered on the approximate 3T tissue T2* (eg, 35 ms). 21, 22 We also used image-based parallel imaging (sensitivity encoding) with an acceleration factor of 1.8 -2.0, which reduces the EPI readout train by an approximate factor of 2. Geometric distortions from offresonant spins and signal drop-out are largely affected by susceptibility gradients, and parallel imaging can reduce these issues by increasing the per-voxel bandwidth in the phase-encoding direction, 23 thereby resulting in a shorter EPI readout (eg, approximately 36 ms without parallel imaging versus 18 ms with parallel imaging by using scan parameters in our sequences). While we used sensitivity encoding in our protocol, which is common on Philips scanners, k-space parallel imaging by using Generalized Autocalibrating Partial Parallel Acquisition or Autocalibrating Reconstruction for Cartesian sampling is more common on Siemens and GE Healthcare scanners, respectively, and performs comparably for reducing geometric distortions when similar acceleration factors are used. In the absence of parallel imaging, partial k-space acquisitions may also be used to reduce geometric distortions.
Limitations
First, information regarding implant manufacturer and type is not known for all implants considered, precluding a rigorous analysis in all patients. However, the composition of implants evaluated is similar to that in other commonly deployed implants; thus, results may generalize. Of the patients with intracranial implants analyzed, 1 (patient 2A) had incomplete information available regarding embolization coils and an ipsilateral stent, though this patient had an artifact size (9.4 cm 3 ) similar to that in another patient (patient 4A) with known platinum embolization coils and an ipsilateral titanium and nickel alloy stent (4.7 cm 3 ). Indeed, most embolization coils are composed of platinum, with only the earliest models containing stainless steel, 24, 25 and most intracranial stents are composed of titanium, titanium alloys, or stainless steel. 24, 26, 27 Thus, our finding that the small artifacts produced by intracranial implants do not impact clinical interpretability of BOLD fMRI is likely generalizable, with the exception of those models of intracranial implants that contain stainless steel, which were not evaluated in our study population and may produce larger artifacts due to higher magnetic susceptibility. Information regarding specific implant manufacturers and composition was not available for a subset of patients with extracranial implants (CVR protocol, n ϭ 2; functional localizer protocol, n ϭ 13). However, those patients with unknown closure hardware had artifact extent and clinical interpretability similar to those in patients with known extracranial hardware, which primarily included closure hardware composed of titanium alloy. Most implanted neurosurgical hardware is composed of titanium or titanium alloys similar to those evaluated in our study, 24, 25 suggesting that results are likely generalizable. We did not evaluate any issues related to the safety of metallic devices; however, this topic has been studied extensively, and all patients were screened by using standard MR imaging safety screening procedures. 9 Second, while BOLD fMRI is the most common noninvasive
